Taro Pharmaceutical Industries Ltd (TARO)
42.26
+0.12
(+0.28%)
USD |
NYSE |
Mar 27, 16:00
42.16
-0.10
(-0.24%)
Pre-Market: 20:00
Taro Pharmaceutical Industries Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
Date | Value |
---|---|
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.0034 |
June 30, 2015 | 0.0037 |
March 31, 2015 | 0.0042 |
December 31, 2014 | 0.0046 |
September 30, 2014 | 0.0141 |
June 30, 2014 | 0.0165 |
March 31, 2014 | 0.0176 |
December 31, 2013 | 0.0193 |
September 30, 2013 | 0.0282 |
June 30, 2013 | 0.0308 |
March 31, 2013 | 0.0323 |
December 31, 2012 | 0.0336 |
September 30, 2012 | 0.0497 |
June 30, 2012 | 0.0551 |
March 31, 2012 | 0.0629 |
December 31, 2011 | 0.0788 |
September 30, 2011 | 0.1133 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2019
--
Maximum
Mar 2019
--
Average
--
Median
Mar 2019
Debt to Equity Ratio Benchmarks
InspireMD Inc | 0.00 |
Ayala Pharmaceuticals Inc | -- |
BiomX Inc | -- |
Alpha Tau Medical Ltd | -- |
Puma Biotechnology Inc | 1.865 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 2.163B |
Total Liabilities (Quarterly) | 384.09M |
Shareholders Equity (Quarterly) | 1.779B |
Current Ratio | 3.602 |